Litix SpA (LTX) Chart

Arizona Gold and Silver Vice President of Exploration Greg Hahn spoke with Steve Darling from Proactive to announce a major milestone at the company’s Philadelphia Project in Arizona, reporting the highest gold grades to date from core drilling on the property. The standout result came from drill hole PC25-136, which intersected 4.91 metres grading 9.20 grams per tonne (gpt) gold, highlighting a robust zone of epithermal quartz and calcite-bearing vein breccia within rhyolitic volcanic rocks. Hahn explained that this new high-grade zone, located in the Rising Fawn area, had previously seen limited exploration and lacked the drilling required for a formal resource estimate. The mineralized interval is surrounded by lower-grade stockwork, indicating a broader halo of gold-bearing material. PC25-136 is the first of six drill holes recently completed to test extensions of earlier high-grade intercepts, targeting both down-dip and along-strike mineralization. Hahn noted that the presence of abundant yellow and green quartz in this zone is geologically significant and comparable to mineralization seen in the historic Oatman gold district, suggesting strong potential for further high-grade discoveries. Importantly, this intercept appears to be relatively shallow in the vein system, enhancing the prospectivity as drilling continues to deeper levels. Ongoing drilling at the Philadelphia Project is focused on following up these new results by targeting deeper extensions of the Rising Fawn zone, with the goal of expanding the mineralized envelope and advancing toward a resource definition. #proactiveinvestors #arizonagoldandsilverinc #tsxv #azs #otcqb #azasf #MiningUpdates #GoldExploration #PhiladelphiaProject #MiningDrilling #GoldAndSilver #JuniorMining #ArizonaMining #DrillResults #MiningStocks #PhiladelphiaProject #GregHahn #PreciousMetals #ProactiveInvestors #ResourceExpansion

Novo Resources Corp executive co-chair Mike Spreadborough and exploration manager Kas De Luca talked with Proactive about the company’s current exploration, strategy and key drilling campaigns underway in 2025. Spreadborough detailed the company's focus on standalone projects with the potential to exceed one million ounces, with current efforts centred on drilling programs at the Balla Balla project, Tibooburra Gold Project, and upcoming activity at the John Bull Project. “We’re not chasing brownfields mill feed for an existing processing plant. We’re looking for something new and exciting,” he said. De Luca shared insights into the Clone prospect at Tibooburra, highlighting its strong geological context and mineralisation indicators. “The clone thrust has been really identified and pinpointed now as a foot wall shear zone… that seems to us both in the drilling and in service to carry most of the mineralisation,” she noted. De Luca said results from surface sampling returned grades up to 89 grams per tonne, and the company has only tested a small fraction of a 60km mineralised trend. Novo expects results from three programs between now and July and continues to assess additional farm-in opportunities as part of its strategy. For more videos from Proactive, give this video a like, subscribe to our channel, and turn on notifications so you never miss an update. #GoldExploration #NovoResources #TibooburraGold #GreenfieldsExploration #JuniorMining #RCDrilling #GoldStocks #AustralianMining #MiningUpdates #ProactiveInvestors

Race Oncology CEO and MD Daniel Tillett talked with Proactive about the opening of patient enrollment at the first Australian clinical site for the RC220 Phase I solid tumour trial. Tillett confirmed that the trial is now underway, with additional sites expected to follow soon. The focus of this early-stage study is to determine a safe and effective combination dose of RC220 with the chemotherapy drug doxorubicin. According to Tillett, “our drug has the advantage… not only does it improve the anti-cancer treatment, but it protects the heart, at least in animals and cells to date.” He noted the choice of Southside Cancer Centre as the initial site, citing the faster startup process compared to public hospitals. Other sites, including Gosford and Wyong, have also received ethics approval and are expected to join the trial following regulatory clearance. Tillett discussed the use of a Bayesian trial design, which allows quicker progression and minimises patient exposure to suboptimal doses. While this approach can introduce uncertainty in timelines, it is expected to be more beneficial overall for patients and the company. Early preclinical data has shown that RC220 can reduce doxorubicin-related toxicity while enhancing cancer treatment outcomes, a combination Tillett described as unique among current therapies. Beyond the trial, Race Oncology is conducting separate preclinical studies to identify the most effective drug combinations using RC220. Tillett noted that more updates on this work are expected in the coming months. Watch the full video to hear more from Daniel Tillett and stay informed on Race Oncology’s developments. ➡️ For more interviews like this, visit Proactive’s YouTube channel. Don’t forget to like the video, subscribe to the channel, and hit the notification bell for future updates. #RaceOncology #RC220 #CancerResearch #ClinicalTrials #OncologyUpdates #Doxorubicin #CardioProtection #BayesianDesign #CancerTreatment #BiotechNews #ProactiveInve

Team Internet CEO Michael Riedl joined Steve Darling from Proactive’s OTC studio in New York City to update the company’s strategic progress across its three core business segments: domains, comparison, and search. Each division, Riedl explained, is navigating a distinct phase of growth, underpinned by a clear long-term vision and strong operational execution. In the domains division, Team Internet continues to serve as a trusted partner to some of the world’s leading web hosting and cybersecurity providers. The company’s expertise in securing and managing global online identities remains a foundational strength, supporting businesses as they establish and protect their digital presence in an increasingly interconnected world. The comparison segment has seen exceptional performance in 2024, with over 40% organic growth year-to-date. Profitability in this division has also surged, with profits increasing by an impressive 75%. This momentum reflects strong consumer demand, effective execution, and the scalability of Team Internet’s comparison platforms. Looking ahead, the company has set its sights on international expansion, with plans to take its successful comparison model beyond Germany into new high-potential markets. Riedl also shared insights into the ongoing transformation of the search business, which is transitioning from the legacy AdSense for Domains model to a more advanced offering known as "Related Search on Content." While the shift presents transitional challenges, the new model is already gaining traction. “Even though this transition gives us some challenges, as demonstrated by our recent reforecast, this business is really going very well,” Riedl noted. He highlighted that the search division is now scaling rapidly, adding nearly $10 million in annual recurring revenue (ARR) every week—a clear signal of its growth potential and strategic importance. The U.S. market continues to play a central role in Team Internet’s overall strategy, currently